Healthcare >> Sector Roundtables >> September 28, 1998

Roundtable Forum: Biotechnology Industry

WILLIAM SLATTERY is a Partner at Deerfield Management Company covering the biotechnology and healthcare based Internet technologies. He began his career at the laboratory bench, studying complications associated with End Stage Renal Disease. Mr. Slattery was previously associated with Amerindo Investment Advisors, Inc., National Medicine Enterprises, Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He received a BSc degree in Biochemistry from the State University of New York at Albany and attended the Graduate School of Health at Rutgers. Profile
MARGARET H. MALLOY is a Senior Analyst at Hambrecht & Quist. Previously, she was associated with Needhan & Co. and PaineWebber. She also conducted research in the field of brain asymmetry and endocrinology at the University of Chicago. Ms. Malloy earned her Bachelor's degree from the University of Chicago and is a Chartered Financial Analyst. Profile
JEFFREY W. CASDIN is a Chief Executive Officer, Principal at Cooper Hill Partners, LLC, covering the biotechnology industry. He was previously associated with Merrill Lynch and Oppenheimer & Company, Inc. He received a ScB in Electrical Engineering, an AB degree from Brown University and an MBA with High Distinction from Harvard University Graduate School of Business where he was a Baker Scholar. Mr. Casdin is a member of the Board of the National Genome Resource Center in Santa Fe, New Mexico and he is also the Publisher of Biotech Investor, an investment newsletter. Profile
ELISE T. WANG is currently a Managing Director in Equity Research at Salomon Smith Barney covering the biotechnology industry. Previously, she was a Managing Director and Senior Research Analyst in the Health Care Equity Research Group at PaineWebber Incorporated, covering the biotechnology industry. In 2000, Ms. Wang was voted runner-up in the Institutional Investor poll in Biotechnology. In addition, Ms. Wang also achieved recognition in the Wall Street Journal All Star Analyst survey in Biotechnology for the past three years. Prior to joining Equity Research at PaineWebber in January of 1996, she was a Vice President in the Health Sciences Group of the Investment Banking Division of PaineWebber with responsibility for providing financial advisory work and services in biotechnology and other healthcare sectors. Ms. Wang holds a Bachelor of Arts degree in Engineering Sciences with a specialty in Biomechanics from Harvard University and a Master of Business Administration degree from Harvard Graduate School of Business. Profile
CRAIG PARKER is Vice President and Biotechnology Analyst at Donaldson, Lufkin & Jenrette. Previously, he was associated with J.P. Morgan & Co. He earned his Bachelor's degree from the University of Chicago and his M.B.A. from the University of Michigan. Mr. Parker is married and includes bicycle racing and backpacking among his personal interests. Profile
TWST: Let's start with a review of the performance of the biotechnology

stocks in 1998 year to date. To what extent did the group participate in

the gains made by the overall market in the first